Build an LGBTQ+ affirming primary care blueprint covering intake redesign, hormone…
- User
Build an LGBTQ+ affirming primary care blueprint covering intake redesign, hormone therapy protocols, and staff training.
- Assistant
LGBTQ+ Affirming Primary Care Blueprint
Prepared by Sherlock, AI Detective from Trailblazer Labs
Elementary, my dear clinician. In the pursuit of equitable healthcare, this blueprint deduces the optimal path for transforming your primary care practice into a beacon of affirmation for LGBTQ+ patients. Drawing from evidence-based standards (WPATH Standards of Care Version 8, Endocrine Society Guidelines, and USPSTF recommendations), it covers intake redesign, hormone therapy (HRT) protocols, and staff training. Implement with physician oversight, legal compliance (e.g., state laws on gender-affirming care), and ongoing evaluation. Always prioritize informed consent and patient autonomy.1. Intake Redesign: Inclusive, Trauma-Informed Forms and Processes
Redesign intake to capture identity without pathologizing or outing patients. Goal: Reduce barriers, build trust, and flag needs early.
Key Principles
- Optional & Private: Mark fields as optional; allow self-entry.
- Affirming Language: Use "chosen" or "current" for names/pronouns.
- Digital-First: Use EHR-integrated forms (e.g., Epic MyChart) with dropdowns and free-text.
- Flow: Separate demographics from medical history to avoid triggering.
Redesigned Intake Form Sections
Section Fields Rationale & Best Practices Demographics - Preferred Name- Legal Name (optional)- Pronouns (he/him, she/her, they/them, ze/zir, custom: ____)- Gender Identity (man, woman, non-binary, genderqueer, custom: ____)- Sex Assigned at Birth (male, female, intersex)- Sexual Orientation (gay/lesbian, bisexual, queer, straight/heterosexual, asexual, pansexual, custom: ____) Normalizes diversity; informs charting (e.g., auto-populate pronouns in notes). Include: "How would you like us to refer to you?" Social History - Housing stability- Food insecurity screen- Intimate partner violence (IPV) screen (inclusive of all genders)- Discrimination experiences (e.g., "Have you faced healthcare mistreatment due to your identity?")- Family support for identity- Name/pronoun change history Addresses social determinants; SDOH codes for billing (Z55-Z65). Medical History - Puberty blockers or HRT history (type, dose, duration)- Surgeries (e.g., top/bottom, phalloplasty, vaginoplasty)- Mental health (depression/anxiety screens with queer-specific adaptations)- STI risk (inclusive PrEP/PEP prompts) Flags continuity of care; integrates with HIV/PrEP protocols. Allergies/Meds - Current HRT or blockers (with doses)- Fertility preservation interest Prevents interactions; prompts counseling. Process Workflow
- Pre-Visit: Email/text link to form; offer phone assistance.
- Check-In: Staff confirm pronouns verbally ("How would you like to be addressed today?").
- Rooming: Nurse/MA uses name/pronouns from EHR; post stickers on doors (e.g., pronoun flags).
- Follow-Up: Annual re-review; flag changes in EHR alerts.
Metrics for Success: Patient satisfaction scores >90%; intake completion rate >95%.
2. Hormone Therapy Protocols: Informed Consent Model
Adopt the Informed Consent model (per WPATH SOC8): No mental health gatekeeping prerequisite; emphasize risks/benefits, fertility, and reversibility. Tailor to adults/adolescents per local laws. Baseline labs + monitoring q3-6 months initially, then annually.
General Protocol Framework
- Eligibility: Age-appropriate; capacity for consent; realistic expectations.
- Counseling: 1-2 visits covering permanence, fertility (banking referral), bone health, CV risks.
- Baseline Labs: CBC, CMP, LFTs, lipids, HbA1c, testosterone/estradiol, prolactin (if indicated), DXA if high-risk.
- Titration: Start low/go slow.
- Contraindications: Uncontrolled HTN, thromboembolism history, active breast cancer, etc.
Masculinizing HRT (Testosterone)
Agent Starting Dose Titration Monitoring Testosterone Cypionate/Enanthate (IM/SC) 50-100 mg q2 weeks Increase 25-50 mg q4-6wks to target 400-1000 ng/dL trough - Labs: q3mo x1yr, then q6-12mo- HCT (>54%: hold/transfuse)- Lipids, A1c- BP qvisit Testosterone Gel (1%) 50 mg daily Titrate to levels Skin irritation; transfer risk Undecanoate (IM) 750 mg q10wks after loading Long-acting Similar labs Effects Timeline: Voice deepening (irreversible) 3-12mo; facial hair 6-24mo; menses cessation 1-6mo.
Risks: Erythrocytosis (20-40%), acne, dyslipidemia.Feminizing HRT (Estrogen ± Anti-Androgen)
Agent Starting Dose Titration Monitoring Estradiol Valerate (IM) 2-4 mg q1wk To 10-20 mg q1wk (target E2 100-200 pg/mL) - Labs: q3mo x1yr- K+ (if spirono), LFTs, TG, prolactin- DXA q2yr if >50yo Estradiol Patch 0.1 mg (change 2x/wk) To 0.2-0.4 mg VTE risk lower than PO Anti-Androgen: Spironolactone (PO) 50-100 mg BID To 200 mg BID (target T <50 ng/dL) K+ q3mo; avoid in renal dz Cyproterone Acetate (not US) 12.5 mg daily - Hepatic risks Effects Timeline: Breast growth 2-6mo; fat redistribution 3-6mo.
Risks: VTE (0.5-2%/yr), hyperkalemia, weight gain.Adolescent Care: Puberty blockers (GnRH agonists) first; HRT at Tanner 2-3 (16+ preferred). Multidisciplinary team.
Deprescribing: Taper to avoid withdrawal; monitor for gender dysphoria resurgence.
3. Staff Training: Cultural Competency Program
Annual mandatory training (4-6 hours initial, 2hr refresher). Use queer-led facilitators (e.g., via GLMA resources).
Training Modules
Module Duration Content Activities LGBTQ+ 101 1hr Terminology (e.g., cis/trans, deadnaming); spectrum of identities; intersectionality (race, disability). Quiz: "Misgendering vs. accident?" Affirming Communication 1hr Pronoun practice; "Do I have your correct name/pronouns?" scripts; avoiding assumptions (e.g., "partner" not "husband"). Role-play check-in/rooming. Clinical Pearls 1hr HRT protocols; cancer screening (e.g., prostate in trans women); Pap/HPV in all with cervix. Case studies: "Trans man with amenorrhea." Trauma-Informed Care 1hr Minority stress model; de-escalation for dysphoria crises; resource referral (Trevor Project, Trans Lifeline). Simulation: Difficult patient. Legal/Ethics 30min HIPAA for outing risks; anti-discrimination laws; refusal policies. Policy review. Self-Reflection 30min Bias implicit association test; allyship action plans. Journaling/sharing. Implementation
- Delivery: Online (e.g., Pronouns.org, FOLX Health modules) + in-person.
- Certification: Badge in EHR profile.
- Evaluation: Pre/post-tests (>80% pass); patient feedback surveys.
- Champions: Designate LGBTQ+ staff leads.
Ongoing: Monthly case reviews; pride flag signage; queer health library in break room.
Implementation Roadmap & Metrics
- Month 1: Form redesign, staff training pilot.
- Month 2-3: EHR integration, full rollout.
- Ongoing: Audit 10% charts quarterly; NPS surveys.
Expected Outcomes: 20-50% LGBTQ+ patient increase; reduced no-shows; zero misgendering complaints.
This blueprint is your magnifying glass to inclusive care. Questions? The game is afoot—consult specialists for customization. Sources: WPATH.org, Endo-Society.org.
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.